Evidence map›Paper›PMID 42211346›Full record

ArticleClinical and translational radiation oncology2026

Prostate cancer radiotherapy in kidney transplant candidates: a planning framework for defining and optimizing transplant-specific organs at risk.

Anna Gueiderikh, Adrien Panis, Sylvain Klotz, Damien Moreau, Yannis Meraouna, Thomas Bessede, Guillaume Reichert, Charles Dariane, Philippe Giraud

Abstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anna GueiderikhHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Adrien PanisHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Sylvain KlotzHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Damien MoreauHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Yannis MeraounaHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Thomas BessedeHôpital Kremlin Bicêtre, APHP, 78 Rue du Général Leclerc, Le Kremlin-Bicêtre 94270, France.
Guillaume ReichertHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Charles DarianeHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.
Philippe GiraudHôpital Européen Georges-Pompidou, APHP, 20, rue Leblanc, Paris 75015, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Kidney transplant candidates increasingly present with localized or locally advanced prostate cancer. While radiotherapy is frequently indicated, current planning guidelines do not account for the surgical constraints of future kidney transplantation. This study proposes a practical planning framework by defining transplant-specific organs at risk (OARs) and evaluating the dosimetric impact of their systematic optimization during prostate cancer radiotherapy. Materials and methods: Through multidisciplinary collaboration between radiation oncologists and transplant surgeons, transplantation-critical structures were identified and delineated, including the bladder dome, ureters, and Results: In prostate-only treatments, active optimization of transplant-specific OARs resulted in a threefold or greater reduction in mean dose to the bladder dome, without compromising target coverage or increasing doses to conventional OARs. Similar dose reductions were observed for ureters and Conclusion: This work establishes a planning framework for integrating kidney transplantation constraints into prostate cancer radiotherapy. Prostate-only radiotherapy allows effective sparing of transplant-critical structures through active optimization, whereas pelvic nodal irradiation inevitably exposes these structures to high doses despite optimization. These findings support transplant-oriented treatment planning and careful selection of pelvic irradiation in kidney transplant candidates.

Identifiers

PMID42211346
PMCPMC13214259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.